{"log_id": 3966042733193585364, "direction": 0, "words_result_num": 43, "words_result": [{"probability": {"variance": 2e-06, "average": 0.998228, "min": 0.996348}, "location": {"width": 117, "top": 168, "height": 27, "left": 164}, "words": "【儿童用药】"}, {"probability": {"variance": 1.7e-05, "average": 0.998045, "min": 0.980309}, "location": {"width": 955, "top": 203, "height": 73, "left": 197}, "words": "已经有在成人及儿童患者中进行的药代动力学和对照临床研究的证据支持本品用于2个月或以上的患"}, {"probability": {"variance": 1.6e-05, "average": 0.998382, "min": 0.973374}, "location": {"width": 993, "top": 238, "height": 71, "left": 150}, "words": "有阑尾炎和或腹膜炎的儿童患者。其中包括一项前瞻性的、随机、对比、开放的临床研究,有542名2"}, {"probability": {"variance": 5.8e-05, "average": 0.997366, "min": 0.948377}, "location": {"width": 996, "top": 280, "height": 70, "left": 152}, "words": "12岁患有复杂性腹腔内感染的儿童患者,其中273名患者接受了哌拉西林他唑巴坦。在2个月以下的儿童"}, {"probability": {"variance": 5.4e-05, "average": 0.994685, "min": 0.975516}, "location": {"width": 644, "top": 316, "height": 53, "left": 147}, "words": "患者中的安全性及疗效尚未确立(见【药代动力学】和【用法用量】"}, {"probability": {"variance": 7e-06, "average": 0.998557, "min": 0.987275}, "location": {"width": 434, "top": 357, "height": 44, "left": 189}, "words": "对肾功能损害的儿童患者,本品尚无推荐剂量"}, {"probability": {"variance": 7e-06, "average": 0.997641, "min": 0.993448}, "location": {"width": 120, "top": 393, "height": 33, "left": 150}, "words": "【老年用药】"}, {"probability": {"variance": 3e-06, "average": 0.998946, "min": 0.989269}, "location": {"width": 953, "top": 431, "height": 68, "left": 185}, "words": "65岁以上的患者不会单纯因为年龄的原因而使发生不良反应的危险性升高。但肾功能不全情况下,应"}, {"probability": {"variance": 0.000545, "average": 0.98641, "min": 0.923456}, "location": {"width": 334, "top": 468, "height": 42, "left": 141}, "words": "当调整给药剂量。(见【用法用量】)"}, {"probability": {"variance": 8e-06, "average": 0.998462, "min": 0.983048}, "location": {"width": 955, "top": 507, "height": 69, "left": 181}, "words": "总体上,老年患者的剂量选择应当慎重,往往需要从给药剂量范围的低限开始,这是由于老年人的肝"}, {"probability": {"variance": 3e-06, "average": 0.998942, "min": 0.993742}, "location": {"width": 758, "top": 545, "height": 57, "left": 135}, "words": "脏、肾脏和心脏功能降低的比例较高,存在合并症和合用其他药物的情况较多见"}, {"probability": {"variance": 0.000345, "average": 0.990388, "min": 0.906459}, "location": {"width": 952, "top": 583, "height": 69, "left": 176}, "words": "本品合剂中每克哌拉西林含64mg(2.79mEq)钠。按常规推荐剂量给药,患者每天摄入的钠为768~"}, {"probability": {"variance": 0.009812, "average": 0.965347, "min": 0.451763}, "location": {"width": 991, "top": 624, "height": 68, "left": 140}, "words": "024mg/d(33.5~4.6mEq)。老年人群对钠负荷过多的利钠反应可能比较迟钝,这对于充血性心衰等疾病"}, {"probability": {"variance": 6e-06, "average": 0.998661, "min": 0.992564}, "location": {"width": 155, "top": 660, "height": 33, "left": 130}, "words": "具有临床重要性"}, {"probability": {"variance": 1e-06, "average": 0.999106, "min": 0.996072}, "location": {"width": 958, "top": 697, "height": 67, "left": 170}, "words": "本品大部分经肾脏排泄,肾功能损害患者使用本品发生中毒反应的危险性较高。因为老年人肾功能减"}, {"probability": {"variance": 7e-06, "average": 0.998263, "min": 0.984951}, "location": {"width": 714, "top": 735, "height": 54, "left": 126}, "words": "退的可能性较大,选择剂量时需要慎重,监测肾功能有助于选择合理的剂量"}, {"probability": {"variance": 2e-06, "average": 0.998183, "min": 0.996038}, "location": {"width": 159, "top": 774, "height": 31, "left": 133}, "words": "【药物相互作用】"}, {"probability": {"variance": 0.00108, "average": 0.982699, "min": 0.902935}, "location": {"width": 141, "top": 814, "height": 27, "left": 124}, "words": "1.氨基糖苷类"}, {"probability": {"variance": 0.007057, "average": 0.942595, "min": 0.775452}, "location": {"width": 264, "top": 810, "height": 46, "left": 722}, "words": "受理号CHB(68"}, {"probability": {"variance": 0, "average": 0.992875, "min": 0.992875}, "location": {"width": 25, "top": 838, "height": 25, "left": 1092}, "words": "粤"}, {"probability": {"variance": 0.008418, "average": 0.965116, "min": 0.508476}, "location": {"width": 952, "top": 847, "height": 70, "left": 160}, "words": "β内酰胺类药物体外与氨基糖苷类混合可引起氨基糖苷类的大幅度失活269云的稀释液和特"}, {"probability": {"variance": 0.006834, "average": 0.978752, "min": 0.521335}, "location": {"width": 723, "top": 886, "height": 52, "left": 119}, "words": "定的浓度条件下,瓶装的含EDTA的哌拉西林他唑巴坦可通过Y型管与阿米"}, {"probability": {"variance": 0.001586, "average": 0.974324, "min": 0.861791}, "location": {"width": 209, "top": 914, "height": 37, "left": 904}, "words": "庆大霉素同时滴注。但"}, {"probability": {"variance": 0.02127, "average": 0.936085, "min": 0.38906}, "location": {"width": 995, "top": 922, "height": 70, "left": 115}, "words": "含EDTA的哌拉西林他唑巴坦不能与妥布霉素通过Y型管同时利备案资料药按SFDA24号令执行"}, {"probability": {"variance": 0.003275, "average": 0.985318, "min": 0.688574}, "location": {"width": 954, "top": 961, "height": 66, "left": 158}, "words": "已经认识到青霉素类药物对氨基糖苷类有灭活作用。据推测青霉素-氨基糖苷类可形成复舍物,这些复"}, {"probability": {"variance": 1.2e-05, "average": 0.998104, "min": 0.980086}, "location": {"width": 996, "top": 998, "height": 66, "left": 113}, "words": "合物对细菌没有抗菌活性,毒性不明。肾功能正常和轻至中度肾功能损害患者本品与妥布霉素相继应用表"}, {"probability": {"variance": 1.3e-05, "average": 0.99867, "min": 0.975759}, "location": {"width": 993, "top": 1036, "height": 66, "left": 113}, "words": "明适当地降低了妥布霉素的血清浓度,但并不显著影响妥布霉素的药代动力学。当需要进行血液透析的终"}, {"probability": {"variance": 1.2e-05, "average": 0.998026, "min": 0.976865}, "location": {"width": 997, "top": 1075, "height": 65, "left": 109}, "words": "末期肾病患者,联合应用氨基糖苷类与哌拉西林时,氨基糖苷类药物(尤其是妥布霉素)的浓度可能显著"}, {"probability": {"variance": 6e-05, "average": 0.9965, "min": 0.961298}, "location": {"width": 997, "top": 1113, "height": 64, "left": 107}, "words": "改变而应该进行监测。由于氨基糖苷类药物对被哌拉西林灭活的易感性不一致,因此在那些联合应用哌拉"}, {"probability": {"variance": 2e-06, "average": 0.998721, "min": 0.99452}, "location": {"width": 649, "top": 1152, "height": 49, "left": 106}, "words": "西林和氨基糖苷类药物的患者中,应仔细考虑氨基糖苷类药物的选择"}, {"probability": {"variance": 0.000187, "average": 0.992168, "min": 0.964902}, "location": {"width": 98, "top": 1194, "height": 25, "left": 104}, "words": "2.丙磺舒"}, {"probability": {"variance": 0.078771, "average": 0.599252, "min": 0.387117}, "location": {"width": 153, "top": 1184, "height": 80, "left": 901}, "words": "药"}, {"probability": {"variance": 0.002918, "average": 0.983627, "min": 0.720895}, "location": {"width": 955, "top": 1226, "height": 66, "left": 144}, "words": "与其他青霉素类相似,哌拉西林他唑巴坦与丙磺舒合并应用可使哌拉西林和他唑巴坦的半衰期延长"}, {"probability": {"variance": 0.00634, "average": 0.976308, "min": 0.486408}, "location": {"width": 998, "top": 1263, "height": 66, "left": 98}, "words": "拉西林的半衰期延长21%,他唑巴坦的半衰期延长71%)、肾脏清除率降低。然而两药的血浆峰浓度均未受"}, {"probability": {"variance": 0, "average": 0.999976, "min": 0.999957}, "location": {"width": 47, "top": 1306, "height": 26, "left": 98}, "words": "影响"}, {"probability": {"variance": 0.000302, "average": 0.991396, "min": 0.952579}, "location": {"width": 120, "top": 1344, "height": 28, "left": 96}, "words": "3.万古霉素"}, {"probability": {"variance": 1.9e-05, "average": 0.998176, "min": 0.979036}, "location": {"width": 459, "top": 1381, "height": 44, "left": 135}, "words": "未发现本品和万古霉素存在药代动力学相互作用"}, {"probability": {"variance": 1e-06, "average": 0.999022, "min": 0.998112}, "location": {"width": 47, "top": 1422, "height": 24, "left": 124}, "words": "肝素"}, {"probability": {"variance": 1.2e-05, "average": 0.998188, "min": 0.980783}, "location": {"width": 953, "top": 1456, "height": 62, "left": 132}, "words": "本品与肝素、口服抗凝药物或其他可能会影响凝血系统包括血小板功能的药物合用期间,应当更频繁"}, {"probability": {"variance": 4.3e-05, "average": 0.995859, "min": 0.974055}, "location": {"width": 326, "top": 1495, "height": 38, "left": 88}, "words": "地进行适当的凝血检验并定期监测"}, {"probability": {"variance": 0.000152, "average": 0.989634, "min": 0.963436}, "location": {"width": 121, "top": 1535, "height": 28, "left": 86}, "words": "5.维库溴铵"}, {"probability": {"variance": 0.000359, "average": 0.993372, "min": 0.88009}, "location": {"width": 956, "top": 1571, "height": 62, "left": 127}, "words": "哌拉西林与维库溴铵合用可延长维库溴铵对神经肌肉的阻滞作用。本品(哌拉西林/他唑巴坦)与维库"}, {"probability": {"variance": 1.6e-05, "average": 0.997528, "min": 0.977551}, "location": {"width": 998, "top": 1608, "height": 63, "left": 81}, "words": "溴铵合用也会出现同样的现象。由于作用机制相似,任何非去极化肌松药产生的神经肌肉阻滞作用在合用"}], "language": 3}